LePure Biotech

LePure Biotech

Single-use solutions for the biopharmaceutical industry. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€100—150m (Dealroom.co estimates Apr 2021.)
Westborough Massachusetts (HQ)
  • Edit

Recent News about LePure Biotech

Edit
More about LePure Biotechinfo icon
Edit

LePure Biotech operates in the biopharmaceutical industry, providing innovative bioprocess solutions. The company serves a diverse range of clients, including global biopharma companies, by offering customized integrated bioprocess solutions. LePure Biotech's business model revolves around research and development, manufacturing, and commercial operations, ensuring high-quality products and services. The company generates revenue through the sale of its bioprocess solutions, which include single-use systems and other bioprocessing equipment. LePure Biotech is recognized for its commitment to technology innovation and adherence to international quality standards, making it a reliable partner for its clients. The company has been acknowledged for its investment value in the healthcare sector and has a strong presence in both domestic and international markets. Key achievements include obtaining the US FDA Type III DMF filing number and being recognized as one of the top healthcare enterprises with investment value.

Keywords: bioprocess solutions, biopharmaceutical, innovation, high quality, continuous improvement, single-use systems, international standards, R&D, manufacturing, commercial operations.

Investments by LePure Biotech

Edit
Stanley Biotechnology (Hangzhou)
ACQUISITION by LePure Biotech Oct 2023